It's a fair reading to say that Moore's Law publication offered a compelling analogy for how technology costs can drop dramatically, and that the NHGRI could definitely use it as a comparison point.
However, it's a stretch to claim it was the decisive informational context for tracking genome sequencing costs.
The real drivers for cost reduction in genomics are often specific scientific breakthroughs, like new sequencing chemistries or better automation in the labs, not just a general understanding of chip scaling.
If our workplace negotiated a pay raise for digital skills based only on generic tech trends and not on the actual value created by our specific work, we'd be leaving money on the table; the specific context matters more.